For the NAVAC Drug and Alcohol Addiction Specialty Competency, study each addiction-science concept as a paired skill: the mechanism itself (tolerance, withdrawal, medication effects) and the chaplain's scope-appropriate response to it. Drill this pairing on written scenarios, because a concept you can recite but cannot apply to a veteran's situation leaves you unprepared for the applied reasoning the credential represents.
Tolerance, Dependence, and Addiction: Why These Terms Are Not Interchangeable
Addiction science separates three overlapping ideas: tolerance, physical dependence, and substance use disorder. Precision matters because each calls for a different response, and conflating them produces stigma and scope errors in pastoral conversations.
Tolerance is a neuroadaptation in which the body responds less to a given dose over time. Physical dependence is a related adaptation in which stopping or sharply reducing a substance triggers withdrawal symptoms. Substance use disorder, by contrast, is a behavioral health condition defined by impaired control, craving, and continued use despite harm — not by pharmacology alone. The crucial insight is that dependence can exist without addiction: a patient on long-term prescribed opioids may be physically dependent yet show no loss of control.
Worked scenario: a veteran recovering from a serious injury takes prescribed opioids, has run out two days early twice, and seems anxious about it. The plausible mistake is labeling him 'an addict' internally or aloud. The better decision is to notice that early refills can reflect tolerance and dependence in a legitimate treatment course, to avoid any diagnostic statement (that is outside the chaplain's role), and to respond to the distress itself while encouraging a conversation with the prescriber. Why it matters: a mislabel can shatter trust, discourage the veteran from seeking help, and misdirect the care conversation entirely.
| Term | Core mechanism | Possible without addiction? | Chaplain-relevant implication |
|---|---|---|---|
| Tolerance | Reduced response to a dose over time | Yes (prescribed meds) | Dose changes are prescriber decisions, not moral ones |
| Physical dependence | Withdrawal on stopping or reducing use | Yes | Never advise abrupt stopping; urge medical supervision |
| Substance use disorder | Impaired control, craving, continued use despite harm | No — it is the defining condition | Respond to behavior and distress, not to labels |
Why Alcohol Withdrawal Can Be Dangerous While Opioid Withdrawal Rarely Is
Pharmacology explains why withdrawal profiles differ. Alcohol and benzodiazepines act on GABA systems, so stopping them can produce severe, medically dangerous withdrawal; opioid withdrawal is intensely uncomfortable but rarely life-threatening.
Depressants such as alcohol and benzodiazepines dampen brain activity through GABA-mediated inhibition. When that inhibition is suddenly removed after heavy, sustained use, the nervous system can rebound into tremor, agitation, seizures, and other serious complications — which is why supervised detoxification is standard practice. Opioids work differently: their withdrawal syndrome involves pain, nausea, diarrhea, and profound discomfort, and while it powerfully drives relapse, it is not typically the direct medical danger that depressant withdrawal is. Stimulant cessation brings a different picture again — exhaustion, low mood, and strong cravings.
The chaplaincy application is a scope rule, not a medical one: never tell a veteran that they can simply stop on their own, and never reassure a family that a drinking veteran's decision to quit cold is safe because 'willpower is all it takes.' The better response is to affirm the wish to stop, state plainly that stopping heavy alcohol use is safest under medical supervision, and encourage contact with the treatment team. This knowledge also shapes visit planning: a veteran in early withdrawal is in acute physical distress, and shortening a visit or returning later can be the more pastorally effective choice.
Screening Versus Assessment: Where the Chaplain's Role Starts and Stops
Screening uses brief validated tools to flag possible problems; assessment is a comprehensive clinical evaluation done by credentialed clinicians. A chaplain learns the tools to recognize cues, not to diagnose or evaluate.
The SBIRT model — screening, brief intervention, and referral to treatment — frames how these functions fit together. Instruments such as CAGE, AUDIT, and DAST are designed to be quick, structured flags, not verdicts. A clinical assessment goes far beyond a screening score: it examines history, severity, co-occurring conditions, and readiness across multiple dimensions. Knowing this distinction keeps the chaplain on solid ground: the skill being tested in this subject area is recognizing when a disclosure warrants a referral, not replicating a clinician's evaluation.
Worked scenario: during a visit, a veteran mentions drinking several beers every night to fall asleep. The plausible mistake is turning the conversation into an improvised interrogation — asking screening-style questions rapid-fire, or worse, privately concluding he 'has alcoholism.' The better decision is to reflect what you heard, note the link he himself made between drinking and sleep (often connected to nightmares or hyperarousal), and suggest the sleep or PTSD services that address the underlying driver. Why it matters: screening tools only work as intended when used by trained staff in the right context, and a chaplain who respects that boundary becomes a trusted bridge into care rather than an unlicensed gatekeeper.
Answering the 'Trading One Drug for Another' Objection to Addiction Medications
Medications for opioid use disorder — methadone, buprenorphine, and naltrexone — work through different mechanisms and are evidence-based treatment, not substitution. Knowing each drug's profile lets a chaplain counter stigma factually and calmly.
Methadone is a full opioid agonist dispensed through specialized opioid treatment programs. Buprenorphine is a partial agonist whose ceiling effect limits overdose risk relative to full agonists, and it is commonly managed in outpatient settings. Naltrexone is an antagonist that blocks opioid effects and requires full detoxification before it can be started. These medications reduce craving and overdose risk by stabilizing brain function — the very functions that opioid use disorder disrupts. Framing them as 'replacing one drug with another' misreads the mechanism and the goal.
Worked scenario: in a group setting, another veteran tells a peer on buprenorphine that he is 'still using.' The plausible mistake is staying silent, or nodding along to keep group harmony. The better decision is a brief, non-argumentative reframe: that buprenorphine is prescribed treatment that steadies brain chemistry and lowers overdose risk, and that staying on it is part of his recovery plan. Why it matters: stigma-driven comments are a known reason people abandon effective treatment, and the chaplain's voice in that moment either reinforces or interrupts the stigma. You do not need to win the debate — you need to protect the veteran's footing in care.
| Medication | Mechanism type | Typical setting | Common misconception to correct |
|---|---|---|---|
| Methadone | Full opioid agonist | Opioid treatment programs | 'It's just legal heroin' — it is a regulated, studied treatment |
| Buprenorphine | Partial opioid agonist | Outpatient care | 'Still using' — it stabilizes rather than intoxicates |
| Naltrexone | Opioid antagonist | Post-detox initiation | 'It does nothing' — it blocks opioid effects and reward |
Veterans with Co-Occurring PTSD and Substance Use: Moral Injury Complicates the Picture
Substance use and post-traumatic stress frequently co-occur, each worsening the other, and moral injury adds a distinct wound. The chaplain's tasks are recognizing the loop, honoring limits on disclosure, and following safety protocols.
A common pattern is self-medication: substances used to blunt nightmares, hypervigilance, or emotional numbing, which then deepens both conditions. Distinguishing moral injury from PTSD sharpens pastoral care — PTSD centers on threat and trauma responses, while moral injury centers on guilt, shame, and betrayal from events that violated deeply held moral beliefs. A veteran may carry both at once, and substance use can be attached to either. Knowing which wound a veteran is describing helps the chaplain choose whether the moment calls for trauma-informed sensitivity or for moral and spiritual work.
Scope and ethics in this population have hard edges. Do not press a veteran to narrate combat events; disclosure must be veteran-led. Never promise unlimited confidentiality — be ready to state, briefly and early, that if safety becomes a concern you will involve the appropriate people. If suicidal thoughts surface, follow your facility's protocol rather than improvising an agreement or managing it alone. Person-first language ('a veteran with a substance use disorder,' never 'an addict') is not a nicety here; it is the ethical posture that keeps a struggling person from becoming a category.
Harm Reduction and Recovery Readiness: Engaging a Veteran Who Is Still Using
Harm reduction meets people at any stage of readiness, and the stages-of-change model teaches responding to ambivalence rather than confronting it. The chaplain keeps the relationship open while the person moves toward care.
The transtheoretical stages-of-change model — precontemplation, contemplation, preparation, action, maintenance — describes readiness as a process, not a switch. Motivational interviewing's spirit pairs with it: roll with ambivalence, draw out the person's own reasons for change, and avoid argument. Harm reduction operates on the same premise of meeting people where they are: naloxone availability, syringe programs, and safer-use guidance reduce death and disease without requiring abstinence first. From a public health view, addiction is a treatable chronic condition, and a return to use signals a need to adjust care, not a moral failure.
Worked scenario: a veteran on your ward is still drinking and has no interest in stopping. The plausible mistake is withholding engagement until he 'gets serious about recovery,' which communicates that your care is conditional. The better decision is to stay present, ask what drinking does for him, and raise overdose and health risks matter-of-factly — including where naloxone fits if opioids ever enter the picture. Why it matters: readiness shifts over time, and the relationship you keep today is often the doorway a person uses weeks later when the moment comes to ask for help.
A Six-Week Study Sequence with a Scenario-Mapping Self-Check
Structure preparation around the paired-skill angle: weeks one and two on mechanisms, week three on screening scope, week four on treatment modalities, week five on special populations and ethics, week six on mixed drills with a scoring rubric.
A workable sequence: Weeks one and two, build flashcards that pair every mechanism (tolerance, dependence, withdrawal profiles, medication classes) with a one-line chaplain response. Week three, practice screening versus assessment by sorting written disclosures into 'flag and refer,' 'clinical assessment territory,' and 'ordinary pastoral care.' Week four, drill the medication table until you can restate each drug's mechanism and its stigma misconception without notes. Week five, run veteran scenarios that mix PTSD, moral injury, and confidentiality edges. Week six, shuffle everything into mixed sets so you must first identify the concept before responding — the skill the pairing approach builds.
Practical exercise and self-check rubric: write ten short scenarios and, for each, record three things — the correct term, whether the situation belongs to screening, assessment, or treatment, and one scope-appropriate chaplain action. Score each entry one point per correct element, plus one for person-first language. Expected observations: early in the sequence you will likely conflate dependence with substance use disorder in prescribed-medication cases and default to clinical language in role decisions; by week six you should separate mechanism from behavior in your notes automatically. Reaching a consistent eight out of ten on this exercise is a meaningful learning milestone — it indicates fluency with the material, not a prediction of any exam result.
- Readiness check 1: you can define tolerance, physical dependence, and substance use disorder without consulting notes and apply each to a written case.
- Readiness check 2: you can name which withdrawal syndromes are medically dangerous and why, and state the corresponding scope rule.
- Readiness check 3: you can restate the three addiction medications, their mechanism types, and one misconception for each.
- Readiness check 4: your ten-scenario exercise consistently scores eight or more points with correct scope calls and person-first language throughout.
References and further reading
Use these references to explore the concepts and check the latest information from the relevant organizations.